Pretax income is the income that a company earns before paying income taxes. Repligen's pretax income for the
three
months ended in Dec. 2024 was $-38.6 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was $-27.0 Mil.
Repligen's pretax margin was -23.04%.
During the past 13 years, Repligen's highest Pretax Margin was 27.34%. The lowest was -4.26%. And the median was 11.12%.
Repligen Pre-Tax Income Historical Data
The historical data trend for Repligen's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Repligen's Pre-Tax Income
For the Medical Instruments & Supplies subindustry, Repligen's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Repligen's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Repligen's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Repligen's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-27.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Repligen (NAS:RGEN) Pre-Tax Income Explanation
Repligen's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as
During the past 13 years, Repligen's highest Pretax Margin was 27.34%. The lowest was -4.26%. And the median was 11.12%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Repligen Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Repligen's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RGEN has been successfully added to your 